Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novartis presents results of phase Ib trial of PI3K pathway inhibitors in advanced solid tumors

Oct. 29, 2012

Results of alisertib phase I/II cancer trial presented

Oct. 29, 2012

Solute carrier family 12 member 2 expression linked to presbycusis

Oct. 29, 2012

Prodrug formulated to deliver simvastatin to skeletal tissue

Oct. 26, 2012

New IL-1 receptor antagonist may ameliorate intestinal inflammation

Oct. 26, 2012

SP-333 demonstrates efficacy as treatment for gastrointestinal diseases

Oct. 26, 2012

Bayer presents promising results from phase III studies of riociguat

Oct. 26, 2012

Ataluren benefits selected patients with cystic fibrosis in phase III trial

Oct. 25, 2012

Compound-loaded artificial bone acts on host cells to induce regeneration

Oct. 25, 2012

Urine MIF could be a useful biomarker of interstitial cystitis

Oct. 25, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...